US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 4.830
- +0.150+3.21%
Close Dec 24 13:00 ET
- 4.830
- 0.0000.00%
Post 17:01 ET
281.63MMarket Cap-16.66P/E (TTM)
4.830High4.650Low292.92KVolume4.650Open4.680Pre Close1.39MTurnover0.56%Turnover Ratio120.75P/E (Static)58.31MShares6.75052wk High0.52P/B254.16MFloat Cap3.46052wk Low--Dividend TTM52.62MShs Float33.440Historical High--Div YieldTTM3.85%Amplitude0.450Historical Low4.760Avg Price1Lot Size
Vanda Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.76%47.65M | 9.59%50.47M | -24.06%47.46M | -24.27%192.64M | -29.79%45.27M | -40.58%38.82M | -28.47%46.06M | 3.83%62.5M | -5.32%254.38M | -5.20%64.48M |
| Operating revenue | 22.76%47.65M | 9.59%50.47M | -24.06%47.46M | -24.27%192.64M | -29.79%45.27M | -40.58%38.82M | -28.47%46.06M | 3.83%62.5M | -5.32%254.38M | -5.20%64.48M |
| Cost of revenue | -16.72%2.55M | -21.89%2.73M | -27.94%3.44M | -39.07%14.8M | -44.53%3.46M | -51.53%3.06M | -42.25%3.5M | -15.73%4.77M | -5.26%24.28M | 0.03%6.24M |
| Gross profit | 26.15%45.1M | 12.18%47.74M | -23.74%44.02M | -22.71%177.84M | -28.21%41.81M | -39.40%35.75M | -27.04%42.56M | 5.86%57.72M | -5.33%230.1M | -5.73%58.24M |
| Operating expense | 34.38%56.1M | 27.44%57.89M | -4.42%53.26M | -14.29%191.8M | -5.25%48.91M | -24.22%41.75M | -17.22%45.42M | -10.41%55.72M | 11.39%223.77M | -2.88%51.62M |
| Selling and administrative expenses | 51.71%37.57M | 39.00%39.47M | -16.67%30.09M | -17.29%112.88M | -27.97%23.61M | -17.04%24.77M | -13.95%28.4M | -11.61%36.1M | 10.03%136.49M | -1.99%32.78M |
| Research and development costs | 1.06%16.78M | 0.08%16.66M | 9.97%21.15M | -10.43%76.82M | 31.89%24.34M | -33.22%16.6M | -22.54%16.65M | -8.26%19.24M | 13.81%85.77M | -4.54%18.45M |
| Depreciation amortization depletion | 360.79%1.75M | 363.49%1.75M | 432.45%2.02M | 37.86%2.09M | 151.45%953K | 0.26%380K | -0.26%378K | 0.00%379K | 2.57%1.52M | 2.71%379K |
| -Depreciation and amortization | 360.79%1.75M | 363.49%1.75M | 432.45%2.02M | 37.86%2.09M | 151.45%953K | 0.26%380K | -0.26%378K | 0.00%379K | 2.57%1.52M | 2.71%379K |
| Operating profit | -83.49%-11M | -253.89%-10.15M | -560.83%-9.24M | -320.45%-13.95M | -207.01%-7.09M | -253.40%-6M | -182.84%-2.87M | 126.13%2M | -84.99%6.33M | -23.24%6.63M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -19.05%4.76M | -15.19%4.63M | 29.71%4.57M | 308.19%20.29M | 82.07%5.43M | 278.30%5.88M | 1,559.27%5.46M | 3,256.19%3.52M | 2,397.99%4.97M | 11,576.92%2.98M |
| Other non- operating income (expenses) | -19.05%4.76M | -15.19%4.63M | 29.71%4.57M | 308.19%20.29M | 82.07%5.43M | 278.30%5.88M | 1,559.27%5.46M | 3,256.19%3.52M | 2,397.99%4.97M | 11,576.92%2.98M |
| Income before tax | -5,103.33%-6.24M | -312.81%-5.52M | -184.37%-4.66M | -43.90%6.34M | -117.28%-1.66M | -102.20%-120K | -31.61%2.59M | 173.08%5.53M | -73.33%11.3M | 11.65%9.61M |
| Income tax | -257.98%-920K | -193.10%-998K | -122.76%-518K | -23.78%3.83M | -73.15%739K | -111.73%-257K | -11.84%1.07M | 300.71%2.28M | -45.45%5.03M | 79.63%2.75M |
| Net income | -3,986.13%-5.32M | -397.24%-4.52M | -227.49%-4.15M | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M |
| Net income continuous Operations | -3,986.13%-5.32M | -397.24%-4.52M | -227.49%-4.15M | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -3,986.13%-5.32M | -397.24%-4.52M | -227.49%-4.15M | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -3,986.13%-5.32M | -397.24%-4.52M | -227.49%-4.15M | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M |
| Basic earnings per share | -3,878.34%-0.09 | -366.67%-0.08 | -216.67%-0.07 | -63.64%0.04 | -133.33%-0.04 | -96.03%0.0024 | -40.00%0.03 | 154.55%0.06 | -81.67%0.11 | -7.69%0.12 |
| Diluted earnings per share | -3,883.10%-0.09 | -366.67%-0.08 | -216.67%-0.07 | -63.64%0.04 | -133.33%-0.04 | -96.04%0.0024 | -40.00%0.03 | 154.55%0.06 | -81.03%0.11 | 0.00%0.12 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data